CompletedNCT01669538
Galantamine Compared With Placebo to Support Quitting Smoking
About this title
Read the official source — NCT01669538Medication studyAges 18–60United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateAugust 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 98
- Sponsor
- University of Pennsylvania
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT01669538
- Official title
Show the full official title
Repurposing Cholinesterase Inhibitors for Smoking Cessation.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pennsylvania, a university.
Did this study involve medication?
Yes. The study involved medication, including Galantamine and Placebo.
Who was this study for?
Listed age limits: 18 years to 60 years.
